Study Summary:
PENTASA in active Crohn’s Disease: A 10-week, double-blind, multi-centre trial comparing PENTASA Sachet 6g/day (Mesalazine, Mesalamine) with placebo.
Qualified Participants Must:
• Have Crohn's disease symptom's at least 3 months prior to first visit
•
Have confirmed diagnosis of CD by MRI, X-ray, and or endoscopy
Qualified Participants May Receive:
Stipend for time and travel, study medication for disease, and free medical exams.